Boundless Bio, Inc. (BOLD) stock
BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.50+0.04 (+1.63%)
Close on Nov 13, 2026Market cap $56.87MP/E –Yield –
Boundless Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Boundless Bio's price to book ratio was 0.8× on Nov 11, 2026, against 0.2× a year earlier. Over the last 2 years it ranged from 0.2× to 1.0×, with a median of 0.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | +0.6 |
| 2025 | Dec 31, 2025 | 0.2× | −0.1 |
| 2024 | Dec 31, 2024 | 0.4× | – |
See a number that looks wrong?